Bile acids: Short and long term effects in the intestine

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 6, 2010, Pages 645-664

  Bajor, Antal ^a   Gillberg, Per Göran ^b   Abrahamsson, Hasse ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Bile acid malabsorption; Bile acid synthesis; Colonic motility; Colonic secretion; Colorectal cancer; Constipation; FGF19; IBS

Indexed keywords

BILE ACID; BISACODYL; CHENODEOXYCHOLIC ACID; CHOLIC ACID; COLESTIPOL; COLESTYRAMINE; DEOXYCHOLIC ACID; FARNESOID X RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 19; GLUCOSE; HYPOCHOLESTEROLEMIC AGENT; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 6; LITHOCHOLIC ACID; LOPERAMIDE; TAUROCHOLIC ACID; TAUROSELCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ANTIMICROBIAL ACTIVITY; BILE ACID BLOOD LEVEL; BILE ACID MALABSORPTION; BILE ACID METABOLISM; BILE ACID SYNTHESIS; BILE DUCT; CANCER RISK; CARCINOGENICITY; CECUM; CLINICAL TRIAL; COLLAGENOUS COLITIS; COLON; COLON CANCER; COLON MOTILITY; COLON MUCOSA; COLON RESECTION; COLORECTAL CARCINOMA; CONSTIPATION; CROHN DISEASE; CYSTIC FIBROSIS; DIARRHEA; DIET THERAPY; DIETARY INTAKE; DISEASE ASSOCIATION; DNA STRAND BREAKAGE; FAMILIAL AMYLOID POLYNEUROPATHY; FUNCTION TEST; GALLBLADDER; GLUCOSE METABOLISM; HUMAN; ILEUM RESECTION; IMMUNE SYSTEM; INTESTINE MOTILITY; INTESTINE MUSCLE; INTESTINE SECRETION; IRRITABLE COLON; LIFESTYLE MODIFICATION; LOW FAT DIET; MALABSORPTION; MYOTONIC DYSTROPHY; NONHUMAN; POSTCHOLECYSTECTOMY SYNDROME; PRIORITY JOURNAL; RADIATION ENTEROPATHY; REVIEW; SMALL INTESTINE; TISSUE DISTRIBUTION; TISSUE LEVEL; WATER CONTENT; WHOLE BODY RADIATION;

ANIMALS; BILE ACIDS AND SALTS; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINES; RISK FACTORS; TIME FACTORS;

EID: 77952160057     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521003702734     Document Type: Review

References (197)

1. Angelin B, Bjorkhem I, Einarsson K, Ewerth S. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J Clin Invest 1982;70:724-731
2. Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 1999;159: 2647-2658
3. Angelin B, Einarsson K, Ewerth S, Leijd B. Biliary lipid composition in obesity. Scand J Gastroenterol 1981;16:1015-1019
4. Northfield TC, McColl I. Postprandial concentrations of free and conjugated bile acids down the length of the normal human small intestine. Gut 1973;14:513-518
5. Hamilton JP, Xie G, Raufman JP, Hogan S, Griffin TL, Packard CA, et al. Human cecal bile acids: concentration and spectrum. Am J Physiol Gastrointest Liver Physiol 2007;293: G256-63.
6. Hofmann AF, Mysels KJ. Bile acid solubility and precipitation in vitro and in vivo: the role of conjugation, pH, and Ca2+ ions. J Lipid Res 1992;33:617-626
7. Matsuoka K, Suzuki M, Honda C, Endo K, Moroi Y. Micellization of conjugated chenodeoxy-and ursodeoxycholates and solubilization of cholesterol into their micelles: comparison with other four conjugated bile salts species. Chem Phys Lipids 2006;139:1-10.
8. Ayaki Y, Tsuma-Date T, Endo S, Ogura M. Role of endogenous and exogenous cholesterol in liver as the precursor for bile acids in rats. Steroids 1981;38:495-509.
9. Gustafsson BE, Angelin B, Einarsson K, Gustafsson JA. Effects of cholesterol feeding on synthesis and metabolism of cholesterol and bile acids in germfree rats. J Lipid Res 1977;18:717-721
10. Duane WC, Adler RD, Bennion LJ, Ginsberg RL. Determination of bile acid pool size in man: a simplified method with advantages of increases precision, shortened analysis time, and decreased isotope exposure. J Lipid Res 1975;16:155-158
11. Low-Beer TS, Pomare EW. Regulation of bile salt pool size in man. Br Med J 1973;2:338-340
12. Lanzini A, Lanzarotto F. Review article: the 'mechanical pumps' and the enterohepatic circulation of bile acids-defects in coeliac disease [In Process Citation]. Aliment Pharmacol Ther 2000;14 Suppl 2:58-61.
13. Kullak-Ublick GA, Paumgartner G, Berr F. Long-term effects of cholecystectomy on bile acid metabolism. Hepatology 1995;21:41-45
14. Fracchia M, Pellegrino S, Secreto P, Pera A, Galatola G. Biliary lipid composition in idiopathic bile acid malabsorption [see comments]. Gut 1998;43:812-816
15. Playoust MR, Isselbacher KJ. Studies on the transport and metabolism of conjugated bile salts by intestinal mucosa. J Clin Invest 1964;43:467-476
16. Hardison WG, Rosenberg IH. Bile-salt deficiency in the steatorrhea following resection of the ileum and proximal colon. N Engl J Med 1967;277:337-342
17. Hofmann AF, Poley JR. Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med 1969;281:397-402.
18. Rutgeerts P, Ghoos Y, Vantrappen G. Kinetics of primary bile acids in patients with non-operated Crohn's disease. Eur J Clin Invest 1982;12:135-143
19. Danielsson A, Nyhlin H, Persson H, Stendahl U, Stenling R, Suhr O. Chronic diarrhoea after radiotherapy for gynaecological cancer: occurrence and aetiology. Gut 1991;32:1180-1187
20. Fromm H, Malavolti M. Bile acid-induced diarrhoea. Clin Gastroenterol 1986;15:567-582
21. Merrick MV. Bile acid malabsorption. Clinical presentations and diagnosis. Dig Dis 1988;6:159-169
22. Thaysen EH, Orholm M, Arnfred T, Carl J, Rodbro P. Assessment of ileal function by abdominal counting of the retention of a gamma emitting bile acid analogue. Gut 1982;23:862-865
23. Nyhlin H, Merrick MV, EastwoodMA. Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT. Gut 1994;35:90-93
24. Ung KA, Kilander AF, Lindgren A, Abrahamsson H. Impact of bile acid malabsorption on steatorrhoea and symptoms in patients with chronic diarrhoea. Eur J Gastroenterol Hepatol 2000;12:541-547
25. Fernandez-Banares F, Esteve M, Salas A, Alsina M, Farre C, Gonzalez C, et al. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am J Gastroenterol 2007;102:2520-2528
26. Smith MJ, Cherian P, Raju GS, Dawson BF, Mahon S, Bardhan KD. Bile acid malabsorption in persistent diarrhoea. J R Coll Physicians Lond 2000;34:448-451
27. Wedlake L, A'Hern R, Russell D, Thomas K, Walters J, Andreyev H. Systematic review: the prevalence of idiopathic bile acid malabsorption (I-BAM) as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome (IBS). Aliment Pharmacol Ther 2009.
28. Suhr O, Danielsson A, Nyhlin H, Truedsson H. Bile acid malabsorption demonstrated by SeHCAT in chronic diarrhoea, with special reference to the impact of cholecystectomy. Scand J Gastroenterol 1988;23:1187-1194
29. Suhr O, Danielsson A, Steen L. Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of gastrointestinal disturbances in familial amyloidosis with polyneuropathy. Scand J Gastroenterol 1992;27:201-207
30. Ung KA, Gillberg R, Kilander A, Abrahamsson H. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut 2000;46:170-175
31. Merrick MV, Eastwood MA, Ford MJ. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br Med J (Clin Res Ed) 1985;290:665-668
32. O'Brien S, Mulcahy H, Fenlon H, O'Broin A, Casey M, Burke A, et al. Intestinal bile acid malabsorption in cystic fibrosis. Gut 1993;34:1137-1141
33. Weber AM, Roy CC, Chartrand L, Lepage G, Dufour OL, Morin CL, et al. Relationship between bile acid malabsorption and pancreatic insufficiency in cystic fibrosis. Gut 1976;17:295-299
34. Walters MP, Littlewood JM. Faecal bile acid and dietary residue excretion in cystic fibrosis: age group variations. J Pediatr Gastroenterol Nutr 1998;27:296-300.
35. Ronnblom A, Andersson S, Danielsson A. Mechanisms of diarrhoea in myotonic dystrophy. Eur J Gastroenterol Hepatol 1998;10:607-610
36. Kuipers F, Stroeve JH, Caron S, Staels B. Bile acids, farnesoid X receptor, atherosclerosis and metabolic control. Curr Opin Lipidol 2007;18:289-297
37. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, et al. Identification of a nuclear receptor for bile acids. Science 1999;284:1362-1365
38. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999;284: 1365-1368
39. Davis RA, Miyake JH, Hui TY, Spann NJ. Regulation of cholesterol-7alpha- hydroxylase: BAREly missing a SHP. J Lipid Res 2002;43:533-543
40. Glaeser H, Bailey DG, Dresser GK, Gregor JC, Schwarz UI, McGrath JS, et al. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin Pharmacol Ther 2007;81:362-370
41. Walters HC, Craddock AL, Fusegawa H, Willingham MC, Dawson PA. Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. Am J Physiol Gastrointest Liver Physiol 2000;279:G1188-200.
42. Ung KA, Olofsson G, Fae A, Kilander A, Ohlsson C, Jonsson O. In vitro determination of active bile acid absorption in small biopsy specimens obtained endoscopically or surgically from the human intestine. Eur J Clin Invest 2002;32:115-121
43. Hruz P, Zimmermann C, Gutmann H, Degen L, Beuers U, Terracciano L, et al. Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis. Gut 2006;55:395-402.
44. Hofmann AF. Biliary secretion and excretion in health and disease: current concepts. Ann Hepatol 2007;6:15-27.
45. Oelkers P, Kirby LC, Heubi JE, Dawson PA. Primary bile acid malabsorption caused by mutations in the ileal sodiumdependent bile acid transporter gene (SLC10A2). J Clin Invest 1997;99:1880-1887.
46. Renner O, Harsch S, Schaeffeler E, Schwab M, Klass DM, Kratzer W, et al. Mutation screening of apical sodiumdependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression. Hum Genet 2009;125:381-391
47. Montagnani M, Love MW, Rossel P, Dawson PA, Qvist P. Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption. Scand J Gastroenterol 2001;36:1077-1080
48. Neimark E, Chen F, Li X, Shneider BL. Bile acid-induced negative feedback regulation of the human ileal bile acid transporter. Hepatology 2004;40:149-156
49. Neimark E, Chen F, Li X, Magid MS, Alasio TM, Frankenberg T, et al. c-Fos is a critical mediator of inflammatory-mediated repression of the apical sodium-dependent bile acid transporter. Gastroenterology 2006;131:554-567
50. Jung D, Fantin AC, Scheurer U, Fried M, Kullak-Ublick GA. Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor. Gut 2004;53:78-84.
51. Grober J, Zaghini I, Fujii H, Jones SA, Kliewer SA, Willson TM, et al. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis- retinoic acid receptor heterodimer. J Biol Chem 1999;274:29749-29754
52. Ballatori N, Christian WV, Lee JY, Dawson PA, Soroka CJ, Boyer JL, et al. OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology 2005;42:1270-1279
53. Dawson PA, Hubbert M, Haywood J, Craddock AL, Zerangue N, Christian WV, et al. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. J Biol Chem 2005; 280:6960-6968
54. Frankenberg T, Rao A, Chen F, Haywood J, Shneider BL, Dawson PA. Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids. Am J Physiol Gastrointest Liver Physiol 2006;290:G912-22.
55. Ballatori N, Fang F, Christian WV, Li N, Hammond CL. Ostalpha-Ostbeta is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver. Am J Physiol Gastrointest Liver Physiol 2008;295:G179-86.
56. Jones S. Mini-review: endocrine actions of fibroblast growth factor 19. Mol Pharm 2008;5:42-48
57. Lundasen T, Galman C, Angelin B, Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med 2006;260:530-536
58. Balesaria S, Pell RJ, Abbott LJ, Tasleem A, Chavele KM, Barley NF, et al. Exploring possible mechanisms for primary bile acid malabsorption: evidence for different regulation of ileal bile acid transporter transcripts in chronic diarrhoea. Eur J Gastroenterol Hepatol 2008;20:413-422
59. Nyhlin H, Brydon G, Danielsson A, Westman S. Clinical application of a selenium (75Se)-labelled bile acid for the investigation of terminal ileal function. Hepatogastroenterology 1984;31:187-191
60. van Tilburg AJ, de Rooij FW, van den Berg JW, Kooij PP, van Blankenstein M. The selenium-75-homocholic acid taurine test reevaluated: combined measurement of fecal selenium-75 activity and 3 alpha-hydroxy bile acids in 211 patients. J Nucl Med 1991;32:1219-1224
61. Farkkila MA, Kairemo KJ, Taavitsainen MJ, Strandberg TA, Miettinen TA. Plasma lathosterol as a screening test for bile acid malabsorption due to ileal resection: correlation with 75SeHCAT test and faecal bile acid excretion. Clin Sci (Lond) 1996;90:315-319
62. Nyhlin H, Merrick MV, Eastwood MA, Brydon WG. Evaluation of ileal function using 23-selena-25-homotaurocholate, a-gamma-labeled conjugated bile acid. Initial clinical assessment. Gastroenterology 1983;84:63-68
63. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001;120:652-668
64. Jazrawi RP, Ferraris R, Bridges C, Northfield TC. Kinetics for the synthetic bile acid 75selenohomocholic acid-taurine in humans: comparison with [14C] taurocholate. Gastroenterology 1988;95:164-169
65. Li YC, Wang DP, Chiang JY. Regulation of cholesterol 7 alpha-hydroxylase in the liver. Cloning, sequencing, and regulation of cholesterol 7 alpha-hydroxylase mRNA. J Biol Chem 1990;265:12012-12019
66. Brydon WG, Nyhlin H, Eastwood MA, Merrick MV. Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol 1996;8:117-123
67. Sauter GH, Munzing W, von Ritter C, Paumgartner G. Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum. Dig Dis Sci 1999;44:14-19.
68. Eusufzai S, Axelson M, Angelin B, Einarsson K. Serum 7 alpha-hydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: correlation to SeHCAT test. Gut 1993;34:698-701.
69. Bajor A, Kilander A, Fae A, Galman C, Jonsson O, Ohman L, et al. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. Eur J Gastroenterol Hepatol 2006;18:397-403.
70. Bajor A, Kilander A, Sjovall H, Rudling M, Ung KA. The bile acid turnover rate assessed with the (75)SeHCAT test is stable in chronic diarrhoea but slightly decreased in healthy subjects after a long period of time. Dig Dis Sci 2008;53:2935-2940
71. Camilleri M, Nadeau A, Tremaine WJ, Lamsam J, Burton D, Odunsi S, et al. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil 2009;21:e734-43.
72. Galman C, Angelin B, Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology 2005;129: 1445-1453
73. Walters JR, Tasleem AM, Omer OS, Brydon WG, Dew T, le Roux CW. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol 2009;7:1189-1194
74. van Faassen A, Hazen MJ, van den Brandt PA, van den Bogaard AE, Hermus RJ, Janknegt RA. Bile acids and pH values in total feces and in fecal water from habitually omnivorous and vegetarian subjects. Am J Clin Nutr 1993;58:917-922
75. Rafter JJ, Child P, Anderson AM, Alder R, Eng V, Bruce WR. Cellular toxicity of fecal water depends on diet. Am J Clin Nutr 1987;45:559-563
76. de Kok TM, van Faassen A, Glinghammar B, Pachen DM, Eng M, Rafter JJ, et al. Bile acid concentrations, cytotoxicity, and pH of fecal water from patients with colorectal adenomas. Dig Dis Sci 1999;44:2218-2225
77. Stadler J, Yeung KS, Furrer R, Marcon N, Himal HS, Bruce WR. Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer. Cancer Lett 1988;38:315-320
78. Hofmann AF, Poley JR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology 1972;62:918-934
79. Mitchell WD, Findlay JM, Macrae R, Eastwood MA, Anderson R. Factors affecting bile acid metabolism in cholerrheic enteropathy. Digestion 1974;11:135-146
80. Reddy BS, Mastromarino A, Gustafson C, Lipkin M, Wynder EL. Fecal bile acids and neutral sterols in patients with familial polyposis. Cancer 1976;38:1694-1698
81. Norman A. Faecal excretion products of cholic acid in man. Br J Nutr 1964;18:173-186
82. Hofmann AF. Bile acids, diarrhea, and antibiotics: data, speculation, and a unifying hypothesis. J Infect Dis 1977;135(Suppl):S126-32.
83. Eastwood MA, Hamilton D. Studies on the adsorption of bile salts to non-absorbed components of diet. Biochim Biophys Acta 1968;152:165-173
84. Duane WC. The intermicellar bile salt concentration in equilibrium with the mixed-micelles of human bile. Biochim Biophys Acta 1975;398:275-286
85. Setchell KD, Lawson AM, Tanida N, Sjovall J. General methods for the analysis of metabolic profiles of bile acids and related compounds in feces. J Lipid Res 1983;24: 1085-1100
86. McJunkin B, Fromm H, Sarva RP, Amin P. Factors in the mechanism of diarrhea in bile acid malabsorption: fecal pH-a key determinant. Gastroenterology 1981;80:1454-1464
87. Thomas LA, Veysey MJ, French G, Hylemon PB, Murphy GM, Dowling RH. Bile acid metabolism by fresh human colonic contents: a comparison of caecal versus faecal samples. Gut 2001;49:835-842
88. Glinghammar B. Toxicological aspects of bile acids and human fecal water on cultered human colon carcinoma cells. Thesis. Karolinska Institute, Stockholm; 2001.
89. Porter JL, Fordtran JS, Santa Ana CA, Emmett M, Hagey LR, Macdonald EA, et al. Accurate enzymatic measurement of fecal bile acids in patients with malabsorption. J Lab Clin Med 2003;141:411-418
90. Aldini R, Roda A, Festi D, Sama C, Mazzella G, Bazzoli F, et al. Bile acid malabsorption and bile acid diarrhea in intestinal resection. Dig Dis Sci 1982;27:495-502. (Pubitemid 12120282)
91. Lapidus A, Akerlund JE, Einarsson C. Gallbladder bile composition in patients with Crohn's disease. World J Gastroenterol 2006;12:70-74
92. Lapidus A, Einarsson K. Effects of ileal resection on biliary lipids and bile acid composition in patients with Crohn's disease. Gut 1991;32:1488-1491
93. Mekhjian HS, Phillips SF, Hofmann AF. Colonic absorption of unconjugated bile acids: perfusion studies in man. Dig Dis Sci 1979;24:545-550
94. Binder HJ, Rawlins CL. Effect of conjugated dihydroxy bile salts on electrolyte transport in rat colon. J Clin Invest 1973;52:1460-1466
95. Camilleri M, Murphy R, Chadwick VS. Dose-related effects of chenodeoxycholic acid in the rabbit colon. Dig Dis Sci 1980;25:433-438 (Pubitemid 10124424)
96. Chadwick VS, Gaginella TS, Carlson GL, Debongnie JC, Phillips SF, Hofmann AF. Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J Lab Clin Med 1979;94:661-674
97. Gordon SJ, Kinsey MD, Magen JS, Joseph RE, Kowlessar OD. Structure of bile acids associated with secretion in the rat cecum. Gastroenterology 1979;77:38-44.
98. Mekjian HS, Phillips SF, Hofmann AF. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J Clin Invest 1971;50:1569-1577
99. Keely SJ, Scharl MM, Bertelsen LS, Hagey LR, Barrett KE, Hofmann AF. Bile acid-induced secretion in polarized monolayers of T84 colonic epithelial cells: structure-activity relationships. Am J Physiol Gastrointest Liver Physiol 2007;292:G290-7.
100. Wingate DL, Phillips SF, Hofmann AF. Effect of glycineconjugated bile acids with and without lecithin on water and glucose absorption in perfused human jejunum. J Clin Invest 1973;52:1230-1236
101. Conley DR, Coyne MJ, Bonorris GG, Chung A, Schoenfield LJ. Bile acid stimulation of colonic adenylate cyclase and secretion in the rabbit. Am J Dig Dis 1976;21:453-458
102. Alrefai WA, Saksena S, Tyagi S, Gill RK, Ramaswamy K, Dudeja PK. Taurodeoxycholate modulates apical Cl-/OHexchange activity in Caco2 cells. Dig Dis Sci 2007;52: 1270-1278
103. Moschetta A, Portincasa P, Debellis L, Petruzzelli M, Montelli R, Calamita G, et al. Basolateral Ca2+-dependent K+-channels play a key role in Cl-secretion induced by taurodeoxycholate from colon mucosa. Biol Cell 2003;95:115-122
104. Sun Y, Fihn BM, Sjovall H, Jodal M. Enteric neurones modulate the colonic permeability response to luminal bile acids in rat colon in vivo. Gut 2004;53:362-367
105. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006;47:241-259
106. Hylemon PB, Harder J. Biotransformation of monoterpenes, bile acids, and other isoprenoids in anaerobic ecosystems. FEMS Microbiol Rev 1998;22:475-488
107. Freel RW, Hatch M, Earnest DL, Goldner AM. Dihydroxy bile salt-induced alterations in NaCl transport across the rabbit colon. Am J Physiol 1983;245:G808-15.
108. Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem 2003;278:9435-9440
109. Poole D, Goodfrey C, Cottrell G, Kirkland J, Pelayo C, Bunnett N, et al. Expression and function of bile acid receptor GpBAR1 in the enteric nervous system. Gastroenterology 2009;136(Suppl 1):A153.
110. Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009;10:167-177
111. Estall JL, Drucker DJ. Glucagon-like Peptide-2. Annu Rev Nutr 2006;26:391-411.
112. Keitel V, Reinehr R, Gatsios P, Rupprecht C, Gorg B, Selbach O, et al. The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology 2007;45:695-704.
113. Keitel V, Cupisti K, Ullmer C, Knoefel WT, Kubitz R, Haussinger D. The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders. Hepatology 2009;50:861-870
114. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002;296:1313-1316
115. Inagaki T, Moschetta A, Lee YK, Peng L, Zhao G, Downes M, et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A 2006;103:3920-3925
116. Raufman JP, Zimniak P, Bartoszko-Malik A. Lithocholyltaurine interacts with cholinergic receptors on dispersed chief cells from guinea pig stomach. Am J Physiol 1998;274(6 Pt 1):G997-1004.
117. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol 2002;23:541-548
118. Chen X, Yang D, Shen W, Dong HF, Wang JM, Oppenheim JJ, et al. Characterization of chenodeoxycholic acid as an endogenous antagonist of the G-coupled formyl peptide receptors. Inflamm Res 2000;49:744-755
119. Dent P, Fang Y, Gupta S, Studer E, Mitchell C, Spiegel S, et al. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes. Hepatology 2005;42: 1291-1299
120. Gupta S, Stravitz RT, Dent P, Hylemon PB. Downregulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway. J Biol Chem 2001;276:15816-15822
121. Qiao L, Han SI, Fang Y, Park JS, Gupta S, Gilfor D, et al. Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Mol Cell Biol 2003;23:3052-3066
122. Stamp DH. Three hypotheses linking bile to carcinogenesis in the gastrointestinal tract: certain bile salts have properties that may be used to complement chemotherapy. Med Hypotheses 2002;59:398-405.
123. Wienbeck M, Karaus M. The effects of deoxycholic and ricinoleic acid on the isolated circular muscle of the cat colon are modified by leucine-enkephalin. Z Gastroenterol 1983;21:365-372
124. Flynn M, Hammond P, Darby C, Taylor I. Effects of bile acids on human colonic motor function in vitro. Digestion 1982;23:211-216
125. Kirwan WO, Smith AN, Mitchell WD, Falconer JD, Eastwood MA. Bile acids and colonic motility in the rabbit and the human. Gut 1975;16:894-902.
126. Falconer JD, Smith AN, Eastwood MA. The effects of bile acids on colonic motility in the rabbit. Q J Exp Physiol Cogn Med Sci 1980;65:135-144
127. Flynn M, Darby C, Hyland J, Hammond P, Taylor I. The effect of bile acids on colonic myoelectrical activity. Br J Surg 1979;66:776-779
128. Snape WJ Jr, Shiff S, Cohen S. Effect of deoxycholic acid on colonic motility in the rabbit. Am J Physiol 1980;238: G321-5.
129. Edwards CA, Brown S, Baxter AJ, Bannister JJ, Read NW. Effect of bile acid on anorectal function in man. Gut 1989;30:383-386
130. Bampton PA, Dinning PG, Kennedy ML, Lubowski DZ, Cook IJ. The proximal colonic motor response to rectal mechanical and chemical stimulation. Am J Physiol Gastrointest Liver Physiol 2002;282:G443-9.
131. Odunsi S, Camilleri M, Bushiglio I, Burton D, Lamsam J, McKiinzie S, et al. Effects of chenodeoxycholic acid on gastrointestinal and colonic transit and bowel function in health volunteers. Gastroenterology 2009;136(Suppl 1):A531.
132. Taylor I, Basu P, Hammond P, Darby C, Flynn M. Effect of bile acid perfusion on colonic motor function in patients with the irritable colon syndrome. Gut 1980;21:843-847 (Pubitemid 11198905)
133. Shiff SJ, Soloway RD, Snape WJ Jr. Mechanism of deoxycholic acid stimulation of the rabbit colon. J Clin Invest 1982;69:985-992
134. Sun Y, Fihn BM, Jodal M, Sjovall H. Inhibition of nitric oxide synthesis potentiates the colonic permeability increase triggered by luminal bile acids. Acta Physiol Scand 2004;180:167-175
135. Mitchell WD, Eastwood MA. Faecal bile acids and neutral steroids in patients with ileal dysfunction. Scand J Gastroenterol 1972;7:29-32.
136. Mitchell WD, Findlay JM, Prescott RJ, Eastwood MA, Horn DB. Bile acids in the diarrhoea of ileal resection. Gut 1973;14:348-353
137. Eastwood MA, Walton BA, Brydon WG, Anderson JR. Faecal weight, constituents, colonic motility, and lactose tolerance in the irritable bowel syndrome. Digestion 1984;30:7-12.
138. Sadik R, Abrahamsson H, Ung KA, Stotzer PO. Accelerated regional bowel transit and overweight shown in idiopathic bile acid malabsorption. Am J Gastroenterol 2004;99:711-718
139. Jacobsen O, Hojgaard L, Hylander Moller E, Wielandt TO, Thale M, Jarnum S, et al. Effect of enterocoated cholestyramine on bowel habit after ileal resection: a double blind crossover study. Br Med J (Clin Res Ed) 1985;290: 1315-1318
140. Rossel P, Sortsoe Jensen H, Qvist P, Arveschoug A. Prognosis of adult-onset idiopathic bile acid malabsorption. Scand J Gastroenterol 1999;34:587-590
141. Hiatt JG, Shamsie SG, Schectman G. Discontinuation rates of cholesterol-lowering medications: implications for primary care. Am J Manag Care 1999;5:437-444
142. Puleston J, Morgan H, Andreyev J. New treatment for bile salt malabsorption. Gut 2005;54:441-442
143. Wedlake L, Thomas K, Lalji A, Anagnostopoulos C, Andreyev HJ. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire. Clin Ther 2009;31:2549-2558
144. Yeoh EK, Horowitz M, Russo A, Muecke T, Robb T, Chatterton BE. Gastrointestinal function in chronic radiation enteritis-effects of loperamide-N-oxide. Gut 1993; 34:476-482
145. Bosaeus I, Andersson H, Nystrom C. Effect of a low-fat diet on bile salt excretion and diarrhoea in the gastrointestinal radiation syndrome. Acta Radiol Oncol Radiat Phys Biol 1979;18:460-464
146. Nelson LM, Carmichael HA, Russell RI, Atherton ST. Use of an elemental diet (Vivonex) in the management of bile acid-induced diarrhoea. Gut 1977;18:792-794
147. Bosaeus I, Carlsson NG, Andersson H. Low-fat versus medium-fat enteral diets. Effects on bile salt excretion in jejunostomy patients. Scand J Gastroenterol 1986;21:891-896
148. Jung D, Inagaki T, Gerard RD, Dawson PA, Kliewer SA, Mangelsdorf DJ, et al. FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. J Lipid Res 2007;48:2693-2700
149. Abrahamsson H, Ostlund-Lindqvist AM, Nilsson R, Simren M, Gillberg PG. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation. Scand J Gastroenterol 2008;43:1483-1488
150. Hofmann AF, Loening-Baucke V, Lavine JE, Hagey LR, Steinbach JH, Packard CA, et al. Altered bile acid metabolism in childhood functional constipation: inactivation of secretory bile acids by sulfation in a subset of patients. J Pediatr Gastroenterol Nutr 2008;47:598-606.
151. King JC. Practical ambulatory therapy of functional constipation. Am J Dig Dis 1955;22:102-108
152. King JC. Bile acids and dioctyl sodium sulfosuccinate in constipation and irritable colon. Am J Gastroenterol 1961;35:50-60.
153. Hepner GW, Hofmann AF. Cholic acid therapy for constipation. A controlled study. Mayo Clin Proc 1973;48(5):56-58
154. Bazzoli F, Malavolti M, Petronelli A, Barbara L, Roda E. Treatment of constipation with chenodeoxycholic acid. J Int Med Res 1983;11:120-123
155. Berg RD. Bacterial translocation from the gastrointestinal tract. Trends Microbiol 1995;3:149-154
156. Schote AB, Turner JD, Schiltz J, Muller CP. Nuclear receptors in human immune cells: expression and correlations. Mol Immunol 2007;44:1436-1445
157. Wallace JL, Miller MJ. Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 2000;119:512-520
158. Biet F, Locht C, Kremer L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med 2002;80:147-162
159. Vidrich A, Buzan JM, Barnes S, Reuter BK, Skaar K, Ilo C, et al. Altered epithelial cell lineage allocation and global expansion of the crypt epithelial stem cell population are associated with ileitis in SAMP1/YitFc mice. Am J Pathol 2005;166:1055-1067
160. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003;4:269-273
161. Halmi P, Lehtonen J, Waheed A, Sly WS, Parkkila S. Expression of hypoxia-inducible, membrane-bound carbonic anhydrase isozyme XII in mouse tissues. Anat Rec A Discov Mol Cell Evol Biol 2004;277:171-177
162. Keane RM, Gadacz TR, Munster AM, Birmingham W, Winchurch RA. Impairment of human lymphocyte function by bile salts. Surgery 1984;95:439-443
163. Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Gouma DJ. Inflammatory and immunologic effects of obstructive jaundice: pathogenesis and treatment. J AmColl Surg 1995;181:567-581
164. Drivas G, James O, Wardle N. Study of reticuloendothelial phagocytic capacity in patients with cholestasis. Br Med J 1976;1:1568-1569
165. Pain JA, Cahill CJ, Bailey ME. Perioperative complications in obstructive jaundice: therapeutic considerations. Br J Surg 1985;72:942-945
166. Greve JW, Gouma DJ, Buurman WA. Bile acids inhibit endotoxin-induced release of tumor necrosis factor by monocytes: an in vitro study. Hepatology 1989;10:454-458
167. Calmus Y, Guechot J, Podevin P, Bonnefis MT, Giboudeau J, Poupon R. Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes. Hepatology 1992;16:719-723
168. Morvay K, Szentleleki K, Torok G, Pinter A, Borzsonyi M, Nawroth R. Effect of change of fecal bile acid excretion achieved by operative procedures on 1,2-dimethylhydrazine-induced colon cancer in rats. Dis Colon Rectum 1989;32:860-863
169. Bernstein C, Bernstein H, Garewal H, Dinning P, Jabi R, Sampliner RE, et al. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Res 1999;59:2353-2357
170. Ochsenkuhn T, Bayerdorffer E, Meining A, Schinkel M, Thiede C, Nussler V, et al. Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer 1999; 85:1664-1669
171. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 2005;589:47-65.
172. Thomas LA, Veysey MJ, Bathgate T, King A, French G, Smeeton NC, et al. Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis. Gastroenterology 2000;119:806-815
173. Kasbo J, Saleem M, Perwaiz S, Mignault D, Lamireau T, Tuchweber B, et al. Biliary, fecal and plasma deoxycholic acid in rabbit, hamster, guinea pig, and rat: comparative study and implication in colon cancer. Biol Pharm Bull 2002;25:1381-1384
174. van Faassen A, Ochsenkuhn T, Houterman S, van der Ploeg EM, Bueno-de-Mesquita BH, Ocke MC, et al. Plasma deoxycholic acid is related to deoxycholic acid in faecal water. Cancer Lett 1997;114:293-294
175. Tong JL, Ran ZH, Shen J, Fan GQ, Xiao SD. Association between fecal bile acids and colorectal cancer: a meta-analysis of observational studies. Yonsei Med J 2008;49: 792-803.
176. Chao A, Thun MJ, Connell CJ, McCullough ML, Jacobs EJ, Flanders WD, et al. Meat consumption and risk of colorectal cancer. JAMA 2005;293:172-182
177. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131 (11 Suppl):3109S-20S.
178. Elwing JE, Gao F, Davidson NO, Early DS. Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women. Am J Gastroenterol 2006;101:1866-1871
179. Cross AJ, Leitzmann MF, Gail MH, Hollenbeck AR, Schatzkin A, Sinha R. A prospective study of red and processed meat intake in relation to cancer risk. PLoS medicine 2007;4:e325.
180. Reddy BS, Hanson D, Mangat S, Mathews L, Sbaschnig M, Sharma C, et al. Effect of high-fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and fecal bile acids and neutral sterols. J Nutr 1980;110:1880-1887
181. Narisawa T, Magadia NE, Weisburger JH, Wynder EL. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N¢-nitro-N-nitrosoguanidine in rats. J Natl Cancer Inst 1974;53:1093-1097
182. Owen RW, Dodo M, Thompson MH, Hill MJ. Fecal steroids and colorectal cancer. Nutr Cancer 1987;9:73-80.
183. Lipkin M, Reddy B, Newmark H, Lamprecht SA. Dietary factors in human colorectal cancer. Annu Rev Nutr 1999;19:545-586
184. Garland CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann N Y Acad Sci 1999;889:107-119
185. Pardi DS, Loftus EV Jr, Kremers WK, Keach J, Lindor KD. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003;124:889-893
186. Koivisto PV. Fecal and biliary bile acid composition after partial ileal bypass operation. Digestion 1988;39:52-60.
187. Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med 1990;323:946-955
188. Buchwald H, Varco RL, Boen JR, Williams SE, Hansen BJ, Campos CT, et al. Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias. Arch Intern Med 1998;158:1253-1261
189. Jess T, Winther KV, Munkholm P, Langholz E, Binder V. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 2004;19:287-293
190. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990;336:357-359
191. Abrams JS, Anton JR, Dreyfuss DC. The absence of a relationship between cholecystectomy and the subsequent occurrence of cancer of the proximal colon. Dis Colon Rectum 1983;26:141-144
192. Blanco D, Ross RK, Paganini-Hill A, Henderson BE. Cholecystectomy and colonic cancer. Dis Colon Rectum 1984;27:290-292
193. Gafa M, Sarli L, Sansebastiano G, Lupi M, Longinotti E, Rigamonti PP, et al. Gallstones and risk of colonic cancer: a matched case-control study. Int Surg 1987;72:20-24
194. Alley PG, Lee SP. The increased risk of proximal colonic cancer after cholecystectomy. Dis Colon Rectum 1983;26:522-524
195. Moorehead RJ, Kernohan RM, Patterson CC, McKelvey ST, Parks TG. Does cholecystectomy predispose to colorectal cancer? A case control study. Dis Colon Rectum 1986;29:36-38
196. Caprilli R, Ciarniello P, De Petris G, Giuliano M, Saltarelli P, Spagnolo A. Do colon and rectum exhibit an opposite cancer risk trend versus cholecystectomy? A case-double control study. Ital J Surg Sci 1989;19: 29-35.
197. Nielsen GP, Theodors A, Tulinius H, Sigvaldason H. Cholecystectomy and colorectal carcinoma: a total-population historical prospective study. Am J Gastroenterol 1991;86:1486-1490